Related Experiment Video

Updated: May 9, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Scleroderma in children: an update

Francesco Zulian1, Giorgio Cuffaro, Francesca Sperotto

  • 1Division of Pediatric Rheumatology, Department of Pediatrics, University of Padua, Padua, Italy. zulian@pediatria.unipd.it

Current Opinion in Rheumatology
|August 6, 2013
PubMed

Insights

Scleroderma in children requires early diagnosis and effective treatment. Recent advancements include new imaging techniques for juvenile localized scleroderma and a validated severity score for juvenile systemic sclerosis, with methotrexate proving effective for localized forms.

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Immunology

Background:

  • Scleroderma is the third most common rheumatic condition in childhood.
  • Early diagnosis and treatment are vital for improving long-term outcomes in pediatric scleroderma.
  • Juvenile localized scleroderma (JLS) and juvenile systemic sclerosis (JSSc) are distinct presentations.

Purpose of the Study:

  • To review recent advancements in the understanding and management of childhood scleroderma.
  • To highlight new developments in outcome measures and treatment strategies.
  • To emphasize the importance of early intervention for pediatric rheumatic diseases.

Main Methods:

  • Review of recent histopathology and clinical association studies.
  • Evaluation of new imaging techniques for outcome assessment in JLS.
  • Analysis of a new severity score development for JSSc.
  • Assessment of evidence supporting methotrexate (MTX) in JLS treatment.

Main Results:

  • New insights into the etiopathogenesis of scleroderma derived from recent studies.
  • Doppler and laser Doppler imaging show utility in monitoring JLS patients.
  • A new severity score for JSSc has been developed.
  • Methotrexate (MTX) is confirmed as a key treatment for JLS.

Conclusions:

  • Imaging plays a crucial role in outcome assessment for JLS.
  • A severity score has been introduced for JSSc.
  • Methotrexate (MTX) is a vital therapeutic agent for JLS.
Abstract

More Related Videos

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis07:12

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis

Published on: February 10, 2026

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...